News
A new study reveals that adults diagnosed with type 1 diabetes face a heightened risk of cardiovascular disease and death ...
23h
HealthDay on MSNRisk for Death, MACE Increased for Patients With Adult-Onset Type 1 DiabetesAdult-onset type 1 diabetes (T1D) is associated with an increased risk for death and major adverse cardiovascular events ...
People who develop type 1 diabetes (T1D) in adulthood have an increased risk of cardiovascular disease and death, a study ...
Diabetic ketoacidosis (DKA) is a build-up of substances ... If ketone levels rise too far, patients can pass out, go into a coma, and even die if levels of ketones aren't quickly reduced.
With a faint voice interrupted by labored breathing and suppressed tears, Hajj Ahmad Darabiya, 87, described his harsh ...
Imbalances in metal ions may play a role in the development of diabetes and its complications. Can they be a novel target for ...
This case did not fit the traditional differential diagnosis of ketoacidosis. Diabetic ketoacidosis, alcoholic ketoacidosis,uremia, lactic acidosis and toxic ingestion were not present.
A pioneering immunotherapy drug to treat type 1 diabetes is soon to be tested on human participants for the first time. Scientists from the University of Queensland want to recruit five people with ...
Mounjaro led to greater average weight loss than Wegovy in a 72-week trial Participants on Mounjaro lost more body weight and had better metabolic outcomes Experts say both drugs are useful but ...
The woman remained in a coma on ventilator support in the intensive care unit of E.M.S. Memorial Hospital, Perinthalmanna. She was given two doses of monoclonal antibodies and other medicines as ...
Any damage to these blood cells and the retina may indicate a diabetes-related eye complication, the most common being diabetic retinopathy. As the damage worsens, you may begin losing your vision.
Just over a year after its first phase 3 trial of its Engensis gene therapy for painful diabetic peripheral neuropathy (DPN) bombed, Helixmith has started dosing patients in a new study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results